These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28067464)

  • 1. Analysis of six 'neuro-enhancing' phenidate analogs.
    Klare H; Neudörfl JM; Brandt SD; Mischler E; Meier-Giebing S; Deluweit K; Westphal F; Laussmann T
    Drug Test Anal; 2017 Mar; 9(3):423-435. PubMed ID: 28067464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural elucidation of phenidate analogues via the ESI-MS/MS spectra of their sodium adduct ions.
    Shamai Yamin T; Prihed H; Madmon M; Shifrovitch A; Baratz A; Weissberg A
    Forensic Sci Int; 2020 Jan; 306():110044. PubMed ID: 31734575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric properties of N-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof.
    Shevyrin V; Kupriyanova O; Lebedev AT; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y; Sadykova R
    J Mass Spectrom; 2016 Oct; 51(10):969-979. PubMed ID: 27388323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
    Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
    Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification and analytical characterization of 2,2'-difluorofentanyl.
    Liu C; Li T; Han Y; Hua Z; Jia W; Qian Z
    Drug Test Anal; 2018 Apr; 10(4):774-780. PubMed ID: 28851108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical profiles of "legal highs" containing cathinones available in the area of Lisbon, Portugal.
    Zancajo VM; Brito J; Carrasco MP; Bronze MR; Moreira R; Lopes A
    Forensic Sci Int; 2014 Nov; 244():102-10. PubMed ID: 25240621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
    Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
    J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of methylphenidate-based designer drugs.
    Luethi D; Kaeser PJ; Brandt SD; Krähenbühl S; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):133-140. PubMed ID: 28823611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances.
    Shevyrin V; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y
    Forensic Sci Int; 2016 Feb; 259():95-100. PubMed ID: 26771874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone.
    Carlsson A; Lindberg S; Wu X; Dunne S; Josefsson M; Åstot C; Dahlén J
    Drug Test Anal; 2016 Oct; 8(10):1015-1029. PubMed ID: 26526273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the chemical profile of designer drugs by ESI(+) and PSI(+) mass spectrometry-An approach on the fragmentation mechanisms and chemometric analysis.
    Dos Santos NA; Macrino CJ; Allochio Filho JF; Gonçalves FF; Almeida CM; Agostini F; Guizolfi T; Moura S; Lacerda V; Filgueiras PR; Ortiz RS; Romão W
    J Mass Spectrom; 2020 Oct; 55(10):e4596. PubMed ID: 32729201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs.
    Westphal F; Girreser U; Waldmüller D
    Drug Test Anal; 2016 Sep; 8(9):910-9. PubMed ID: 26606897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS.
    Borth S; Hänsel W; Rösner P; Junge T
    Forensic Sci Int; 2000 Dec; 114(3):139-53. PubMed ID: 11027867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
    Liu C; Jia W; Hua Z; Qian Z
    Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical analysis of two new designer drugs: buphedrone and pentedrone.
    Maheux CR; Copeland CR
    Drug Test Anal; 2012 Jan; 4(1):17-23. PubMed ID: 22113925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
    Ammann D; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):381-9. PubMed ID: 22593565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.